Chemokine receptor type 4 (CXCR4) has been suggested to regulate cell migration and invasion in human somatic cells. However, its role in human oocytes and embryos has not been investigated directly. Here we show that CXCR4 mRNA was initially expressed at the 4-cell stage, and its expression gradually increased until the blastocyst stage, whereas its protein was detectable only after the 8-cell stage. In addition, CXCR4 mRNA and protein were expressed in the inner cell mass (ICM) and trophectoderm (TE) cell of the blastocyst. Furthermore, we collected embryos from women whose embryos had undergone successful implantation (SI) and those whose embryos had failed implantation (FI) in their fresh cycles. TE cells from the FI group had reduced CXCR4 mRNA expression relative to those from the SI group but not in the ICM. Through ICM replacement, we constructed mouse blastocysts in which Cxcr4 was specifically knocked down in TE cells to simulate the CXCR4 expression profile of human blastocysts from the FI group. In this case, we found that the implantation rate significantly decreased after transfer of reconstructed embryos. Bioinformatic analysis indicated that CXCR4 can induce cell apoptosis and migration mediated by Rho signaling. This hypothesis was confirmed by invasion and migration experiments, using a human trophoblast cell line. The present study is the first to explore the characteristics of CXCR4 expression using human oocytes and embryos and suggests that CXCR4 is required upstream of TE cell apoptosis and migration. CXCR4 expression is a potential biomarker to predict implantation competence during assisted reproductive technologies.
INTRODUCTION
Approximately 50 to 70 million couples worldwide are infertile and have turned to assisted reproductive technology (ART) to overcome their infertility [1] . Previous research has estimated that so far there have already been more than 5 million ART births around the world, and infertility rates in some countries are likely to rise [2] . With the development of science and technology, ART has the potential to conquer infertility, although this process is frequently inefficient, as shown by the implantation rate, the rate of ongoing pregnancy, and the rate of live births [3] .
Successful implantation is the first step during the intrauterine growth of the fetus and directly affects ART outcome. Implantation is closely related to multiple factors related to the woman and the embryo, including endometrial health, endocrinology, pre-existing diseases, embryo quality, and genetics [4, 5] . Studies have also screened mRNAs or micro-RNAs involved in the molecular mechanism of implantation, but these studies have used animal models or in vitro cell models, which weakens their clinical significance [6, 7] . Use of the combined approach of collecting clinical samples and conducting retrospective analyses to find potential genes, with their subsequent functional validation using animal models, may thus prove to be effective.
Chemokine receptor type 4 (CXCR4) is a chemokine receptor and was first identified in 1996 as a coreceptor of human immunodeficiency virus [8] . CXCR4 belongs to the superfamily of G protein-coupled seven-transmembrane proteins that signal by activating heterotrimeric Ga proteins [9] . Cxcr4 is essential for hematopoiesis and organogenesis, as well as for vascularization [10, 11] . CXCR4 is highly expressed in various kinds of tumors and is the most widely expressed chemokine receptor in cancer [12] . In addition, CXCR4 is transcribed and translated by both human trophoblasts and decidual stromal cells [13, 14] . Wu et al. [15] demonstrated that trophoblast cells express functional CXCR4, which may play an important role in early pregnancy such as stimulating trophoblast cell proliferation or differentiation in an autocrine manner.
Growing evidence has suggested that the signaling pathway mediated by CXCR4 is important in the proliferation, differentiation, and invasion of cells. Based on analyses of cultured trophoblasts, Jaleel et al. [16] determined that the CXCR4 signaling pathway promotes trophoblast survival and proliferation during pregnancy by stimulating antiapoptotic pathways such as the MAPKERK1/2 pathway [17] . In addition, CXCR4 induces cell migration and invasion through EGFR/ERK [18, 19] , PI3K/AKT/FOSL1 [20, 21] , JAK2/ STAT3 [22] , and Rho/ROCK signaling pathways [23] , especially in cancer cells. However, expression profiling of CXCR4 in human preimplantation embryos has yet to be reported, and understanding its role during human embryo implantation requires further investigation.
In the present study, we collected surplus embryos from patients who were pregnant and from patients for whom ART had failed, and we performed retrospective analyses of their ART outcomes. CXCR4 expression, in both the successful implantation (SI) group and the failed implantation (FI) group, was determined, and the results were compared. By using reconstructed mouse blastocysts that simulated CXCR4 expression characteristics from human blastocysts, the role of CXCR4 in implantation was confirmed. Potential cellular pathways mediated by CXCR4 were analyzed with bioinformatics and identified using a human trophoblast cell line.
MATERIALS AND METHODS

Ethics
The present study was approved by the Institutional Review Board of Peking University Third Hospital. All patients involved in this study were informed of the experimental details and signed the informed consent form voluntarily. For mice, all experimental procedures were performed according to the legislation on the care and use of experimental animals in Peking University Third Hospital.
Collection of Human Oocytes and Fertilized Embryos
Human oocytes and sperm were donated by couples who had gone through ART cycles. When more than 30 oocytes were retrieved from a female patient during oocyte collection, she could donate 2 or 3 fresh metaphase II (MII) oocytes for the present study. In total, 25 oocytes were donated by 10 couples. Five oocytes at MII stage were collected for mRNA expression identification. The surplus oocytes were fertilized, and the fertilized embryos were cultured until the 2-or 4-cell stage. Five embryos at the 2-cell stage and seven embryos at the 4-cell stage were collected for mRNA expression identification. Embryos at the 8-cell and blastocyst stages were donated by couples who had delivered a healthy baby through ART treatment and who voluntarily discarded the surplus cryopreserved embryos and were willing to donate them to the present study. In total, 106 embryos at the 8-cell stage were donated by 23 couples. Nineteen embryos at the 8-cell stage were collected for mRNA (5 embryos) and protein (14 embryos) expression identification. Surplus embryos were cultured until the blastocyst stage. Five blastocysts were individually placed in PCR tubes with 5 ll of lysis buffer, and the other 26 blastocysts were used for protein expression assay.
To determine CXCR4 expression in the SI and FI groups, 160 patients undergoing in vitro fertilization or cycles of intracytoplasmic sperm injection between March 2014 and December 2014 participated in this experiment. A total of 224 poor quality embryos that did not meet the requirements for embryo transfer on Day 3 of these procedures were donated by the couples involved.
Culture of Human Fertilized Embryos
All collected embryos were cultured in an atmosphere of 5% CO 2 , 5% O 2 , 90% N 2 at saturated humidity (three embryos in 15 ll of medium under mineral oil). Embryos from each of the patients were cultured in one dish. Some of the embryos at the 8-cell stage were vitrified immediately for further molecular analysis, and the others were examined on Days 5 and 6, when they had developed into blastocysts. Blastocysts were also vitrified for further molecular analysis.
Morphological Quality Assessment of Blastocysts
Blastocysts were graded based on the morphology of their inner cell mass (ICM), trophectoderm (TE) cells, and the extended degree of the blastocoel. Blastocysts were graded using the system described by Dokras et al. [24] . Grade 1 blastocysts (BG1) have a blastocoel with an eccentric shape at the early stage and an expanded cavity later, lined by a distinct region of ICM and TE cells. BG2 blastocysts have individual or multiple vacuoles with sharply concave borders at the early stage and are delayed in their development of an expanded blastocyst by 1-2 days, although they eventually have a similar morphology compared with BG1 blastocysts. BG3 blastocysts have a vacuolated appearance at the early stage and have extensive degenerative foci in the region of the ICM and TE cells.
RNA Isolation and Real-Time PCR
CXCR4 expression was analyzed by real-time PCR [25] . Total RNA from individual embryos was extracted using a single-cell RNA isolation kit (Clontech). Complementary DNA was synthesized and amplified from total RNA and was subjected to PCR with primers for CXCR4, using GAPDH as the control. Real-time PCR was performed using an ABI 7500 instrument with SYBR Select Master Mix (Applied Biosystems). Samples were amplified for 40 cycles of 958C for 15 sec, 568C for 15 sec, and 728C for 1 min. To normalize the readings, we used the cycle threshold (C t ) value from Gapdh as the internal control for each run, obtaining a DC t value for each gene. Relative changes in gene expression data were analyzed by using the 2 -DDC t method. The primer sequences are shown in Supplemental Table S1 (all Supplemental Data are available online at www.biolreprod.org).
Immunocytochemistry
Embryos were washed three times in phosphate-buffered saline (PBS) and then fixed in 4% paraformaldehyde for 30 min. They were then rinsed again three times in PBS and treated with 1% Triton X-100 at 48C overnight. The resulting permeabilized embryos were incubated in blocking solution (0.1% Tween 20 in PBS containing 2% bovine serum albumin and 5% normal goat/ rabbit serum) for 1 h at room temperature and were then rinsed in PBS three times. Next, the embryos were incubated with primary antibodies against CXCR4 (1:100 dilution; product ab1671; Abcam) in blocking solution for 1 h at room temperature. The samples were then incubated with tetramethylrhodmine (TRITC) conjugated secondary (1:200 dilution, goat IgG, ZF-0317, ZSGB-BIO, Beijing) or fluorescein isothiocyanate (FITC) conjugated secondary (1:200 dilution, goat IgG, ZF-0314, ZSGB-BIO, Beijing) for 1 h at room temperature. Hoechst dye 33342 (1:100 dilution; catalog H3570; Invitrogen) was added during the last 5 min to label the nucleus. Immunofluorescence was visualized using confocal microscopy (model LSM 710; Zeiss).
Western Blot Analysis
Western blot analysis was carried out as described previously [26] . A group of embryos was collected and lysed in radioimmunoprecipitation assay lysis buffer, and the protein concentration was quantified with a method based on bicinchoninic acid. From each sample, 40 lg of protein was collected and loaded onto a 5% stacking gel and a 12% separating gel and run at a constant 80 V for 30 min, followed by 120 V for 1.5 h. Proteins were electrotransferred to a polyvinylidene fluoride (PVDF) membrane at a constant 100 V for 90 min. The PVDF membrane was blocked using 5% milk in Tris-buffered saline (TBS) solution (20 mM Tris, pH 7.5; 500 mM NaCl; 0.05% Tween 20) and then was hybridized with primary antibody overnight at 48C. The treated PVDF membrane was then rinsed three times using TBS solution and incubated with horseradish peroxidase-conjugated secondary antibody. Bound antibodies were visualized using an enhanced chemiluminescence detection system (Amersham Pharmacia Biotechnology). The intensity of the bands was determined using Carestream MI software (Kodak), and the relative amount of each target protein was estimated using b-actin as the internal control. All primary antibodies were purchased from Abcam, including CXCR4 (product ab52625), VCL (product ab18058), ACTN1 (product ab50599), PFN1 (product ab154593), BCL-2 (product ab59348), CASP3 (product ab44976), and BAX (product ab10813).
Mouse Oocyte Collection
B6D2F1 and ICR female mice (8-10 weeks of age; weight, 28.2-32.5 g) were kept under standard conditions of temperature (23 6 28C) and relative humidity (65 6 5%) and on an artificial light 12L:12D schedule (lights on at 08:00 hours). Food and water were available ad libitum.
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Each female mouse was injected intraperitoneally with 10 IU of pregnant mare serum gonadotropin and 48 h thereafter with 10 IU of human chorionic gonadotropin. They were sacrificed 14 h later by cervical dislocation. Cumulusoocyte complexes from each oviduct were collected, and the cumulus cells were removed using hyaluronidase.
Construction of Mouse Blastocysts with Cxcr4 Knockdown in TE Cells
Small interfering RNA (siRNA) specific for Cxcr4 was purchased from GenePharma Co. Ltd. (product A10003). The siRNA powder was diluted using diethypyrocarbonate (DE-PC) water and then injected into mouse MII oocytes. Successful inhibition was confirmed by real-time PCR. Oocytes injected with DE-PC water were used as controls.
Following our established protocol [27] , intracytoplasmic sperm injection was then performed on the oocytes in the siRNA and control groups. The formation of a female and male pronucleus was considered successful fertilization. Twenty fertilized embryos were incubated in one drop of CZB culture medium at 378C under 5% CO 2 and 95% humidity for 4 days to the blastocyst stage. The ICM was then removed from each embryo by micromanipulation [28] , and then an ICM from a control group blastocyst was injected into each blastocoel surrounded by TE cells from the siRNA group.
Embryo Transfer and Implantation Spot Observation
For embryo transfer, ICR female mice in estrus were mated with vasectomized ICR male mice. The presence of a vaginal plug the following morning confirmed a successful mating. The fertilized siRNA and control embryos at the blastocyst stage were then transferred to the uteri of these pseudopregnant ICR females at 2.5 days postcoitus. The ICR female mice were killed and dissected on Day 10.5, and their uteri were collected. The implantation spot for each of the siRNA and control blastocysts was observed and calculated.
Migration and Invasion Assays
The human trophoblast cell line HTR8-SVneo was cultured in 24-well plates under three conditions: cells were grown without supplementation; cells were supplemented with 100 lM of the CXCR4 antagonist Plerixafor (PL; product S8030; Selleck Chemicals), and cells were supplemented with PL and 500 nM CN04 (product CN04-A; Cytoskeleton Inc.), an activator of the Rho pathway. After 2 days, the cells were dissociated in 0.25% trypsin and resuspended in serum-free medium. For the migration assay, ;10 5 cells/ml were seeded on the upper chamber without Matrigel (356234, Corning, NY). For the invasion assay, 12.5% (v/v) Matrigel (diluted in serum-free culture medium) was added to a membrane with 8-lm pores. After the membrane was incubated at 378C for 1 h, ; 5 3 10 5 cells/ml were seeded on this membrane. For both assays, 600 ll of culture medium was then added to the lower chamber. After 1 day, the cells that were able to cross the membrane were fixed and stained with crystal violet (Sigma-Aldrich). The number of cells was counted in six randomly chosen fields under 1003 magnification.
Statistical Analysis
The results were compared using SPSS software (version 17.0, Chicago, IL). An independent sample t-test was performed to compare gene expression data from the two groups. One-way ANOVA was used when data from three or more groups were compared. Chi-square analysis was used to compare the number of embryos between two groups. P values ,0.05 were considered significant. Each experiment was repeated at least three times.
RESULTS
Clinical Data and Blastocyst Grading
The average age of patients within the two groups is presented in Table 1 . The mean age and basic physical indices of the patients in the SI group were not significantly different from those in the FI group. Moreover, the number of oocytes retrieved was also not significantly different between the two groups, but the number of qualified embryos that could be transferred was significantly increased in the SI group. The cumulative pregnancy rate in the FI group was significantly lower than that in the SI group (Table 1) . Blastocysts were morphologically assessed on Day 5 or 6 after fertilization and classified as BG1, BG2, or BG3. The number of blastocysts in each category did not differ significantly between the two groups (P ¼ 0.175; Fig. 1 ).
mRNA Expression and Protein Localization of CXCR4
CXCR4 expression was examined in human oocytes and preimplantation embryos. CXCR4 expression was observed at the 4-cell stage and gradually increased until the blastocyst stage ( Fig. 2A) . Considering the different cellular types in blastocysts, CXCR4 expression was then checked in ICM and TE cells. Expression of CXCR4 was noted in both types of cells, with a comparable level of CXCR4 expression in TE cells RELEVANCE BETWEEN CXCR4 AND EMBRYO IMPLANTATION (Fig. 2B) . Protein expression was also checked in human embryos at the 8-cell and blastocyst stages by Western blotting and immunofluorescence methods. The results confirmed that CXCR4 expression at the 8-cell stage was so weak that it was barely detected but was present in both ICM and TE cells in blastocysts (Fig. 2, C-E) . Immunofluorescence analysis at the blastocyst stage indicated that CXCR4 is located in both the cytoplasm and the cytomembrane of blastocysts (Fig. 2, F-I) .
We then compared CXCR4 expression levels in human 8-cell embryos and blastocysts in the FI group with those in the SI group. Down-regulation of CXCR4 expression was detected in embryos from the FI group frequently compared with that in the SI group, whether in 8-cell embryos or in blastocysts (Fig.  3, A and B) . To confirm this result, we compared CXCR4 expression in individual embryos at either the 8-cell or blastocyst stage from both groups. Overall expression of CXCR4 in all embryos from the SI group was significantly higher than that in embryos from the FI group, except for one embryo (Supplemental Fig. S1, A and B) . CXCR4 expression levels in multiple embryos from individual patients were also determined. CXCR4 expression was almost comparable among three embryos from the same individual, although a few embryos showed the opposite expression characteristics (Supplemental Fig. S1C ). Moreover, CXCR4 expression in ICM cells did not dramatically differ between the two groups, but in TE cells, CXCR4 expression in the SI group was significantly higher than in the FI group (Fig. 3, A and C) . In addition, we analyzed CXCR4 expression in 8-cell embryos and blastocysts from both groups. CXCR4 was still undetectable in 8-cell embryos of both groups, and the resulting expression profiles in blastocysts, ICM, and TE were similar to the changes in mRNA expression (Fig. 3, D-F) .
Down-Regulation of CXCR4 Expression in TE Cells Impairs Implantation in Mice
To verify the role of CXCR4 during implantation, its expression was inhibited by injection of a CXCR4-specific siRNA. A significant expression down-regulation was confirmed by real-time PCR in the blastocysts from these siRNAinjected Cxcr4 knockdown (Cxcr4 kd ) oocytes (Fig. 4A) . Early development of embryos did not seem to be affected by Cxcr4 mRNA knockdown (Fig. 4B) . The blastocysts were transferred into uteri of pseudopregnant female mice, and the mice were dissected on Day 10.5. The number of implantation spots in the siRNA group was significantly lower than that in the control group (Fig. 4, C and D) , which indicated that Cxcr4 is a key element for embryo implantation.
To mimic the expression characteristics of CXCR4 in the human FI group, an ICM replacement experiment was performed. We transferred the ICM from a normal blastocyst into a Cxcr4 kd blastocyst from which the ICM had been removed and reconstructed the new blastocyst ICM wt -TE kd (Fig. 4E) (Fig. 4F) .
Potential Cellular Pathways Mediated by CXCR4
We then analyzed the potential signaling pathways related to CXCR4 using the Pathway Unification database. We screened 30 cellular pathways that were related to CXCR4 and found that some of them were related to inflammation and stress (Table 2) . We then used bioinformatics analysis to look for potential interactions between CXCR4 and the other proteins in the STRING (search tool for the retrieval of interacting genes/proteins) database and found that CXCR4 may act on the Rho complex and therefore could regulate the expression of apoptosis-related proteins and migration-related proteins (Fig. 5A) .
To confirm this hypothesis, the human trophoblast cell line HTR8-SVneo was cultured in vitro and treated with the CXCR4 antagonist PL. PL treatment inhibited cell migration and invasion; however, the migration and invasion of PLtreated cells was improved by the addition of CN04, an activator of the Rho pathway (Fig. 5, B and C) . Protein expression analysis confirmed that expression of actin-and apoptosis-related proteins was significantly changed in the presence of the CXCR4 antagonist and could be restored with CN04 treatment (Fig. 5D) . Relative CXCR4 mRNA expression level in the SI group was significantly higher than that in the FI group in both 8-cell embryos and blastocysts. C) Relative CXCR4 mRNA expression in the ICM in the SI group was similar to that in the FI group, but its expression in TE cells from the SI group was significantly higher than that in the FI group. D) CXCR4 expression in different cell samples is shown between the SI and FI groups. E) Relative CXCR4 expression in the SI group was significantly higher than that in the FI group for blastocysts. No positive signal was detected in 8-cell embryos. F) Relative CXCR4 expression levels in the ICM in the SI group were similar to those in the FI group, but its expression level in TE cells from the SI group was significantly higher than that in the FI group. Error bars represent SEM. *P , 0.05.
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DISCUSSION
In the present study, we demonstrated a correlation between CXCR4 expression and implantation by conducting basic research and using retrospective analysis of clinical data. We also describe for the first time gene expression profiling and protein localization for CXCR4 and illustrate the potential cellular pathways in which it is involved. We found that Cxcr4 knockdown in mouse oocytes contributed to the significant decrease in implantation rate of fertilized embryos, which accorded with the results from our human retrospective analysis. Using bioinformatics analysis, we found that CXCR4 might have participated in the Rho pathway and potentially impaired cell migration and invasion, which was confirmed by in vitro cellular experiments.
The implantation rate among human embryos is related to multiple factors [4, 5] . Demographic and epidemiological studies have indicated that female fecundity decreases with increasing age, with human fertility declining as early as the middle of the third decade [29] . We did not, however, find a statistically significant difference between the age of individuals from the SI group and that in the FI group. Moreover, the other physiological indexes were also similar between the two groups, except for the number of embryos that were transferrable. It is well known that only high-quality embryos should be transferred and that their quality is closely related to the prognosis of pregnancy. In contrast to clinical data, we found that the quality of blastocysts in this study was similar when the discarded embryos from both groups were cultured sequentially, and even high-quality blastocysts were observed from the FI group. This phenomenon may be related to the self -FIG. 4 . Identification of Cxcr4 function during implantation using a mouse model. A) Cxcr4 expression was decreased in blastocysts from siRNA-injected oocytes. B) Developmental efficiency was not impaired in preimplantation Cxcr4 kd embryos. C) Embryo implantation efficiency significantly decreased after embryos were transferred into recipient mice. D) Representative uterus morphology after dissection is shown on Day 10.5. The left uterus is from a mouse that received blastocysts from siRNA-injected oocytes; the right uterus is from a mouse that received control blastocysts. E) Schematic diagram for the reconstructed blastocysts with Cxcr4 knockdown only in TE cells. F) Knockdown of Cxcr4 expression in TE cells significantly impaired implantation, but knockdown in ICM cells seemed not to affect implantation. Error bars represent SEM. *Significantly higher implantation rate is shown in type IV blastocysts compared with types I and III blastocysts; P , 0.05. #Significantly higher implantation rate is shown in type II blastocysts than in types I, III, and IV blastocysts; P , 0.05.
BAO ET AL.
correction ability of human embryos [30, 31] . Therefore, we shifted our focus to the differences in intracellular factors of blastocysts between the two groups.
In our study, real-time PCR data indicated that 8-cell embryos and blastocysts from the FI group had lower expression of CXCR4 than those from patients in the SI group. This suggests that CXCR4 is an important factor in the regulation of implantation of human blastocysts. Based on the high degree of conservation of the implantation process in mammals, CXCR4 is believed to be responsible for motherembryo cross-talk and regulation of embryo implantation [32] . However, our understanding of the function of the CXCR4 pathway in the context of human early embryonic development and implantation is incomplete. In previous studies related to the expression and function of CXCR4 and its ligand CXCL12 in humans, the research samples were almost invariably firsttrimester placentas, which develop mainly from trophoblast cells; results from those studies indicate that CXCR4 functions to stimulate trophoblast cell proliferation and differentiation in an autocrine-like manner [13] [14] [15] . In contrast to previous postimplantation studies, our study demonstrated that higher CXCR4 expression occurred in TE cells before implantation, which increases its potential for clinical applications. Moreover, we were the first to find that CXCR4 mRNA was expressed at the human 8-cell stage, at which point the human zygotic genome is activated, whereas CXCR4 expression was not detected until the blastocyst stage. These data also served as potential evidence for the function of CXCR4 in human implantation. Growing evidence has suggested that the CXCL12/CXCR4 axis plays a vital role in the proliferation, differentiation, and invasion of the embryo.
On the basis of our results, we suggested two ways in which abnormal expression of CXCR4 impaired human embryo implantation, including inducing cell apoptosis and blocking cell migration. Jaleel et al. [16] demonstrated that CXCL12/ CXCR4 promotes trophoblast survival and proliferation during pregnancy by stimulating antiapoptotic pathways in cultured trophoblasts, such as the MAPKERK1/2 pathway. In addition to trophoblast cells, the relationship between CXCR4 expression and cell apoptosis has also been observed in mesenchymal stem cells, cancer cells, stromal cells, and neurons [33] [34] [35] [36] . The CXCL12/CXCR4 axis is likely to moderate different effect FIG. 5 . Analysis and identification of potential regulatory pathways mediated by CXCR4. A) Pathways related to CXCR4 are shown. CXCR4 reacted with two molecules in the Rho pathways, CDC42 and RAC1, and then induced the expression of apoptosis-related and migration-related proteins. B) Images for cell migration and invasion ability testing. B1-B3) migration experiments. B1 is the control group, B2 is the PL group, and B3 is the PL plus CN04 group. B4-B6) Invasion experiments. B4 is the control group, B5 is the PL group, and B6 is the PL plus CN04 group. Bar ¼ 500 lm. C) Statistical analysis of cell numbers from migration and invasion experiments. PL treatment led to a reduction in migration and invasion ability, and CN04 supplementation restored these abilities in the TE cell line. D) Expression of potential downstream proteins in the CXCR4 pathway when CXCR4 expression was modified. Error bars represent SEM. *P , 0.05.
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proteins to activate unique intracellular signaling cascades, such as MAPK, JNK, p38, and PI3K pathways [32] .
Invasion and migration are the most important characteristics of trophoblast cells. In our study, we found that the invasion and migration abilities of trophoblast cells were impaired when CXCR4 expression was inhibited. Several key signaling pathways, such as EGFR/ERK, MAPK-P38, PI3K/ AKT/FOSL1, JAK2/STAT3, and MEK/ERK1/2 signaling pathways, have been suggested to regulate trophoblast cell invasion and migration through CXCR4 [17-19, 22, 37, 38] . Nevertheless, we found that the Rho pathways seems to play a key role in this process as well. Expression of RAC1, RhoA, and CDC42, all of which are involved in the Rho pathway, declined when CXCR4 expression was down-regulated. Rho belongs to the Ras superfamily of low-molecular-weight GTPases and acts as a molecular switch involved in various intracellular signaling pathways such as ACK, PAKs, MEKKs, and ROCK. Rho is well known as a participant in many physiological activities including cell migration, adhesion, cytokinesis, proliferation, differentiation, and apoptosis. A role for Rho in regulating trophoblast cell migration was indicated in recent studies by using Rho guanosine diphosphate dissociation inhibitors, including in mouse, rabbit, and human systems [39] [40] [41] [42] ; however, no reports have been published on the regulation of CXCR4 and Rho-related genes in trophoblast cells. The CXCL12/CXCR4 signaling axis can enhance cell migration toward CXCL12 by antagonizing the down-regulation of ROCK1 expression [43] . Krook et al. [44] suggested that CXCR4-dependent migration and invasion are inhibited by small-molecule inhibitors of CDC42 and RAC1, mechanistically implicating these Rho-GTPases as downstream mediators of the CXCR4-dependent phenotype. In contrast, Feng et al. [45] indicated that CXCR4 might be a downstream effector for Rho E in gastric cancer. These results suggest that CXCR4 and Rho-related genes can regulate one another, which was also shown in our results using trophoblast cells.
In summary, our data provide the first description of CXCR4 mRNA expression and protein localization in human preimplantation embryos. Reduced expression of CXCR4 was tightly related to implantation failure in ARTs, most likely by inducing apoptosis and blocking migration of TE cells. The present results justify further investigation into the role of CXCR4 as a marker for the implantation outcome in ART. 
